ask="3.50"
ask_size="300"
average_daily_volume="467810"
bid="2.83"
bid_size="400"
book_value="0.44"
change="-0.06"
change_from_200_day_moving_average="0.91"
change_from_50_day_moving_average="0.71"
change_from_52_week_high="-0.48"
change_From_52_week_low="1.88"
change_in_percent="-2.03%"
close="2.90"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.10"
ebitda="-24.72M"
eps_estimate_current_year="-1.13"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-0.94"
ex_dividend_date="N/A"
float_shares="20320000"
high="3.00"
high_52_weeks="3.38"
last_trade_date="2/24/2017"
last_trade_price="2.90"
last_trade_size="17673"
last_trade_time="4:00pm"
low="2.80"
low_52_weeks="1.02"
market_capitalization="68.00M"
moving_average_200_day="1.99"
moving_average_50_day="2.19"
name="CymaBay Therapeutics Inc."
notes="N/A"
one_year_target_price="5.67"
open="3.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+45.88%"
percent_change_from_50_day_moving_average="+32.64%"
percent_change_from_52_week_high="-14.30%"
percent_change_from_52_week_low="+184.31%"
previous_close="2.96"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.79"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="23447000"
short_ratio="0.45"
stock_exchange="NCM"
symbol="CBAY"
volume="474980"
weeks_range_52="1.02 - 3.38"
